MADORRA INC.
Therapeutic ultrasound medical device for treating vaginal dryness in breast cancer survivors and postmenopausal women
- Sector
- Medtech
- Headquarters
- Portland, OR
- Total capital
- $7.9M
- Federal grants
- $7.9M
- 8 awards · 2016–2025
- Rank in peer group#260 of 538
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 9 pending · first 2020
- Rank in peer group#190 of 538
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · At-home, ultrasonic device for treatment of vulvovaginal atrophy$486K
- Federal grantHealth and Human S · Phase II · At-home, ultrasonic device for treatment of vulvovaginal atrophy$1.5M
- Federal grantHealth and Human S · Phase II · Developing a novel, non-hormonal treatment paradigm for vaginal dryness in breast cancer survivors$848K
- Federal grantHealth and Human S · Phase II · Developing a novel, non-hormonal treatment paradigm for vaginal dryness in breast cancer survivors$2M
- Federal grantHealth and Human S · Phase II · Developing a novel, non-hormonal treatment paradigm for vaginal dryness in breast cancer survivors$1.2M
- Federal grantHealth and Human S · Phase II · Developing a novel, non-hormonal treatment paradigm for vaginal dryness in breast cancer survivors$300K
- Federal grantNSF · Phase II · SBIR Phase II: Developing a Novel, Non-Hormonal Device for Vaginal Atrophy for Breast Cancer Survivors and Post-menopausal Women$1.4M
Show 1 earlier federal award
- Federal grantNSF · Phase I · SBIR Phase I: Developing a Novel, Non-Hormonal Device for Vaginal Atrophy for Breast Cancer Survivors and Post-menopausal Women$175K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grants#260 · top 48%
- Granted patents#190 · top 35%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 2 granted of 11- GrantedUltrasound Device With Attachable ComponentsUSPTOUS 12,599,786
- PendingUltrasound Device For Vulvovaginal RejuvenationUSPTOApplication 18553486
- PendingUltrasound Device For Vulvovaginal RejuvenationUSPTOApplication 18054062
Show all 11 patent records
- Ultrasound Device With Attachable ComponentsApr 14, 2026 · US 12,599,786Granted
- Ultrasound Device For Vulvovaginal RejuvenationMay 30, 2024 · Application 18553486Pending
- Ultrasound Device For Vulvovaginal RejuvenationNov 23, 2023 · Application 18054062Pending
- Assessment Device For Vulvovaginal RejuvenationSep 7, 2023 · Application 18053588Pending
- Disposable Component For Vaginal Ultrasound Therapy DeviceSep 29, 2020 · US D,897,543Granted
- Ultrasound Device For Vulvovaginal RejuvenationFeb 28, 2019 · Application 15767286Pending
- Hand Held Device to Treat Vaginal Dryness and AtrophyApplication 62242370Pending
- Ultrasound Device For Vulvovaginal RejuvenationApplication PCTUS2022022863Pending
- Assessment Device For Vulvovaginal RejuvenationApplication 63263747Pending
- Ultrasound Device With Attachable ComponentsApplication PCTUS2020042496Pending
- Ultrasound Device For Vulvovaginal RejuvenationApplication PCTUS2016057119Pending
Related companies, and why
- MadorraShares a founder: Holly Rockweiler
- Timothy KellerSimilar federal contract value in Medtech · null in contracts
- BIOGRAFT, INC.Similar federal contract value in Medtech · null in contracts
- MORPHIX TECHNOLOGIES, INC.Similar federal contract value in Medtech · null in contracts
- INTELLISAFE ANALYTICS LLCSimilar federal contract value in Medtech · null in contracts
- SEGMEDIX, CO.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .